Robert W. Dubois, MD, PhD
Robert W. Dubois, MD, PhD, is the chief science officer and executive vice president of the National Pharmaceutical Council (NPC). In this role, he oversees NPC’s research on policy issues related to comparative effectiveness research, as well as on how health outcomes are valued.
Dr. Dubois, who is board certified in internal medicine, brings more than 25 years of experience in health services research and comparative clinical effectiveness. He has co-founded and led various health care research organizations in developing quality research with practical application. Most recently, he was the Chief Medical Officer at Cerner LifeSciences, where he focused on comparative effectiveness and the use of an electronic health records infrastructure to implement clinical change.
Prior to joining Cerner in 2001, Dr. Dubois co-founded Protocare Sciences and was its executive vice president, chief medical officer, and later its CEO.
Throughout his career, Dr. Dubois’ primary interest has centered on defining “what works” in health care and finding ways for that evidence to inform health care decision making. He is a recognized expert in the areas of defining best practice, disease management and appropriateness of care. He has authored more than 100 peer-reviewed articles on comparative effectiveness, evidence-based medicine, the development of practice guidelines and determining the optimal use of high-cost medical services.
Dr. Dubois received his AB from Harvard College, his MD from the Johns Hopkins School of Medicine and his PhD in Health Policy from the RAND Graduate School. He is a member of the Medicare Evidence Development and Coverage Advisory Committee, Steering Committee for the Electronic Data Methods Forum, and the Advisory Board of the Institute for Clinical and Economic Review. Additionally, he is the associate editor of the Journal of Comparative Effectiveness Research and is on the editorial board for Health Affairs.
Selected Publications and Presentations
- Dubois RW. From methods to policy: key questions remain unanswered. JCER 2014;3(1):9-10.
- Dubois RW, Feldman M, Lustig A, Kotzbauer G, Penso J, Pope SD, Westrich KD. Are ACOs Ready to be Accountable for Medication Use? J Manag Care Pharm. 2014 Jan;20(1):17-21.
- Basu A, Jena AB, Goldman DP, Philipson TJ, Dubois R. (2013), Heterogeneity in action: The role of passive personalization in comparative effectiveness research. Health Econ doi: 10.1002/hec.2996